The top 5 most-viewed content from the American Society for Preventive Cardiology (ASPC) Congress on Cardiovascular Disease (CVD) Prevention included interviews with Stephen Nicholls, PhD, MBBS, and Emelia J. Benjamin, MD, ScM, as well as coverage on multiple areas of cardiovascular medicine.
Our top coverage of the American Society for Preventive Cardiology Congress on Cardiovascular Disease (CVD) Prevention included interviews with Stephen Nicholls, PhD, MBBS, about the SURPASS-CVOT study on tirzepatide, and with Emelia J. Benjamin, MD, ScM, where she emphasized the importance of preventing atrial fibrillation (AFib). Top coverage also included studies on racial differences in left ventricular (LV) mass among female patients with obesity, higher in-hospital mortality rates among women than men who developed mechanical complications (MC) following acute myocardial infarction (AMI), and a mobile app that positively influenced self-care and potentially survival outcomes among patients with heart failure (HF).
Here are the ASPC Congress on CVD Prevention 2023 highlights. Click here to catch up on all of our coverage from the conference.
5. How SURPASS-CVOT Spotlights Tirzepatide for Cardiovascular Outcomes: Dr Stephen Nicholls
In an interview, Stephen Nicholls, PhD, MBBS, Monash University and Victorian Heart Hospital, described the patient characteristics in the SURPASS-CVOT trial; patients had type 2 diabetes, a body mass index greater than 25 kg/m2, were at high cardiovascular risk, and had clinically manifested atherosclerotic CVD. COVID-19 did present challenges, but recruitment continued successfully, possibly reflecting excitement about tirzepatide. The trial, comparing tirzepatide to dulaglutide, faced COVID-19–related difficulties, including ensuring patient visits and addressing the potential impact of COVID-19 on clinical events. Nicholls explained that investigators addressed these challenges by closely working with sites, emphasizing the importance of health advice, promoting up-to-date vaccine status, and leveraging the closer relationship between patients and site clinicians in clinical trials.
4. More Black vs White Patients Have Risk Factors for LV Hypertrophy
A study analyzed cardiovascular risk factors and LV mass index (LVMI) in Black and White young adult female patients classified as obese, using data from the National Growth and Health Study. The analysis of 553 patients revealed significant differences between Black and White cohorts in various cardiovascular risk variables, including weight, body mass index, waist circumference, hip circumference, insulin levels, glucose levels, blood pressure, and more. The study suggested potential racial differences in cardiovascular risk factors among young adults, emphasizing the need for future research to explore social determinants of health and various adiposities to address disparities in cardiovascular outcomes. The study's limitations include a population of only Black and White female patients and the use of less accurate echocardiogram for LVMI measurement compared with cardiac MRI.
3. In-Hospital Mortality Elevated Among Female Patients Who Had AMI and MC
Research presented at the ASPC Congress on CVD Prevention revealed higher in-hospital mortality rates among female patients compared to male patients who developed MC following AMI. The data covered the period from January 2012 through December 2020 using the National In-Patient Sample and found that female patients with AMI and MC had a 39% higher rate of in-hospital mortality than male patients. Additionally, female patients without MC showed reduced rates of vasopressor use, acute kidney injury, percutaneous coronary intervention, coronary artery bypass graft, circulatory support, and mechanical ventilation compared with those with MC.
2. App Effectively Maintains, Manages HF Self-Care Following Discharge
The Heart Failure Health Storylines (HFHS) mobile health app, which is designed for post-discharge self-care in patients with HF, positively impacted patients’ ability to maintain and manage recommended care regimens, potentially influencing survival outcomes. According to research, the app users demonstrated increased confidence in behaviors such as medication adherence, exercise, low-sodium diet, obtaining health information, and recognizing health changes compared with those using only discharge instructions. The findings suggest that incorporating mobile health apps in post-discharge care strategies could optimize patient education, adherence to self-care, and reduce HF-related readmissions and health care costs. The study emphasized the importance of supplementing discharge instructions with mobile app use for improved self-care confidence among patients with HF.
1. The Importance of Examining and Preventing Atrial Fibrillation
Emelia J. Benjamin, MD, ScM, recipient of the Honorary Fellow of the American Society for Preventive Cardiology (ASPC) award, delivered a lecture on the prevention of AFib at the ASPC Congress on CVD Prevention. In an interview, Benjamin discussed various aspects of AFib, including risk factors, prevention strategies, connections between AFib and noncardiovascular health conditions, and long-term data on stroke. She emphasized the imperative to focus on preventing AFib and shared insights on the importance of early intervention and managing risk factors to reduce the burden of AFib.
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
AUA to Focus on Inclusive Care, Robotic Surgeries, and Future of Urology at 2024 Annual Meeting
May 1st 2024The American Urological Association (AUA) 2024 Annual Meeting will highlight the latest innovations and future trends in urology, featuring dynamic plenary sessions, educational opportunities for providers, and discussions on cutting-edge treatments and global health initiatives.
Read More
OptumRx’s Jon Mahrt Discusses “Irresponsible” Drug Pricing for Products With Multiple Indications
April 30th 2024When the same product comes to market with additional indications, irrational pricing decisions result in ever increasing prices instead of volume translating to lower costs, said Jon Mahrt, MBA, of OptumRX.
Read More